Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gopinathan

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Advances in Biochemical Psychopharmacology|January 1, 1980
Evaluation of Parkinson's diseaseA Lieberman, M Dziatolowski, G Gopinathan, et al.
Neurology|February 1, 1979
Lergotrile in Parkinson disease: further studiesA N Lieberman, G Gopinathan, E Estey, et al.
Annals of Neurology|January 1, 1983
Bromocriptine and lisuride in Parkinson diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Neurology|March 1, 1979
Bromocriptine in Parkinson disease: further studiesA N Lieberman, M Kupersmith, G Gopinathan, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
Journal of Dental Research|July 30, 2021
Successful Application of a Galanin-Coated Scaffold for Periodontal RegenerationW Ma, H Lyu, M Pandya, et al.
Neurology|February 1, 1984
Combined use of benserazide and carbidopa in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
The American Journal of the Medical Sciences|September 1, 1985
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson diseaseA N Lieberman, M Leibowitz, G Gopinathan, et al.
New York State Journal of Medicine|January 1, 1984
Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitorA N Lieberman, G Gopinathan, A Neophytides, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Advances in Biochemical Psychopharmacology|January 1, 1980
Evaluation of Parkinson's diseaseA Lieberman, M Dziatolowski, G Gopinathan, et al.
Neurology|February 1, 1979
Lergotrile in Parkinson disease: further studiesA N Lieberman, G Gopinathan, E Estey, et al.
Annals of Neurology|January 1, 1983
Bromocriptine and lisuride in Parkinson diseaseA N Lieberman, G Gopinathan, A Neophytides, et al.
Neurology|March 1, 1979
Bromocriptine in Parkinson disease: further studiesA N Lieberman, M Kupersmith, G Gopinathan, et al.
Clinical Pharmacology and Therapeutics|December 1, 1981
Cardiac effects of pergolideM Leibowitz, A Lieberman, M Goldstein, et al.
Journal of Dental Research|July 30, 2021
Successful Application of a Galanin-Coated Scaffold for Periodontal RegenerationW Ma, H Lyu, M Pandya, et al.
Neurology|February 1, 1984
Combined use of benserazide and carbidopa in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
European Neurology|January 1, 1983
Further studies with lisuride in Parkinson's diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
The American Journal of the Medical Sciences|September 1, 1985
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson diseaseA N Lieberman, M Leibowitz, G Gopinathan, et al.
New York State Journal of Medicine|January 1, 1984
Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitorA N Lieberman, G Gopinathan, A Neophytides, et al.
Pageof 5